Shaolin Capital Management’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-23,662
| Closed | -$140K | – | 700 |
|
|
2022
Q4 | $140K | Sell |
23,662
-3,838
| -14% | -$22.7K | ﹤0.01% | 423 |
|
|
2022
Q3 | $193K | Hold |
27,500
| – | – | 0.01% | 462 |
|
|
2022
Q2 | $399K | Hold |
27,500
| – | – | 0.01% | 505 |
|
|
2022
Q1 | $1.03M | Buy |
27,500
+3,525
| +15% | +$133K | 0.03% | 450 |
|
|
2021
Q4 | $1.87M | Sell |
23,975
-30,092
| -56% | -$2.35M | 0.05% | 405 |
|
|
2021
Q3 | $5.45M | Buy |
54,067
+715
| +1% | +$72.1K | 0.17% | 161 |
|
|
2021
Q2 | $5.32M | Buy |
53,352
+1,326
| +3% | +$132K | 0.16% | 144 |
|
|
2021
Q1 | $5.11M | Buy |
+52,026
| New | +$5.11M | 0.22% | 93 |
|